[1]
. О. В. Земляніцина, “ANTIFIBROTIC EFFECT OF COMBINATION DAPAGLIFLOSIN AND METFORMIN THERAPY IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON-ALCOHOLIC FATTY LIVER DISEASE”, PEP, vol. 68, no. 2, pp. 27-33, Jun. 2019.